Long dedicated to the research, development and production of steroid medicine, the company has plenty of know-how in the field of steroid medicine synthesis and has built a technical team with high technical level and rich practical experience. Moreover, the company is competent in pharmaceutical synthesis pathway innovation, new BPC development, green reform of processes and equipment optimization and acquainted with domestic and overseas technical specifications for pharmaceutical studies and laws regulating registration. By now, the company’s bulk pharmaceutical chemicals have gained more than 50 registration numbers in China, with 11 of them registered at FDA and 12 at CEP.